|
Age at diagnosis (years)
|
13 (6–21)
|
|
Time since diagnosis (years)
|
4.4 (0.5–15.3)
|
|
Peak VO2 (L/min)
|
1.9 ± 0.9
|
|
% Predicted peak VO2 (%)
|
81 ± 20
|
|
Haemoglobin, g/L
|
129 (93, 184)
|
|
Sex
|
|
Male
|
10 (50%)
|
|
Female
|
10 (50%)
|
|
Diagnosis
|
|
Acute lymphoblastic leukaemia
|
12 (60%)
|
|
Acute myeloid leukaemia
|
5 (25%)
|
|
Hodgkin rumour
|
2 (10%)
|
|
Wilms rumour
|
1 (5%)
|
|
Treatment Details
|
|
Anthracycline, cumulative dose exposure (mg/m2)
|
175 (89–670)
|
|
Chest-targeted radiation
|
2 (10%)
|
|
Craniospinal radiation
|
2 (10%)
|
|
Total body radiation
|
2 (10%)
|
|
Allogeneic SCT
|
2 (10%)
|
|
Cardiovascular risk factors
|
|
Hypertension
|
1 (5%)
|
|
Diabetes
|
2 (10%)
|
|
Dyslipidaemia
|
3 (15%)
|
|
Chronic renal insufficiency
|
1 (5%)
|
|
BMI > 25 kg/m2
|
3 (15%)
|
